Financhill
Back

KBC Groupe NV Vs. Viking Therapeutics Industry Stock Comparison

Sell
39

KBCSY
KBC Groupe NV

Last Price:
35.32
Seasonality Move:
2.9%
Sell
47

VKTX
Viking Therapeutics

Last Price:
52.96
Seasonality Move:
1.76%
Sell
39
KBC Groupe NV (KBCSY) is a Sell

Is KBC Groupe NV a Buy, Sell or Hold?

  • The current KBC Groupe NV [KBCSY] share price is $35.32. The Score for KBCSY is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • KBCSY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $52.96. The Score for VKTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KBCSY Stock Price Chart

What is KBC Groupe NV's stock price today?

  • The KBC Groupe NV share price today is $35.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KBCSY is experiencing buying pressure, which is a positive indicator for future bullish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $52.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.

KBCSY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 45.58 Sell
Chaikin Money Flow: 12648 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.02 - 36.4) Sell
Bollinger Bands (100): (34.73 - 37.81) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.9 Sell
Relative Strength Index (14 RSI): 43.41 Sell
Chaikin Money Flow: 113403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.34 - 60.74) Sell
Bollinger Bands (100): (47.23 - 79.29) Sell

KBCSY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.54 Sell
20-day SMA: 35.55 Sell
50-day SMA: 36.62 Sell
200-day SMA: 33.35 Buy
8-day EMA: 35.4 Sell
20-day EMA: 35.64 Sell
50-day EMA: 36.09 Sell
200-day EMA: 34.69 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.6 Buy
20-day SMA: 53.66 Sell
50-day SMA: 63.66 Sell
200-day SMA: 39.18 Buy
8-day EMA: 51.13 Buy
20-day EMA: 54.21 Sell
50-day EMA: 59.37 Sell
200-day EMA: 45.7 Buy

KBC Groupe NV Earnings Growth & KBCSY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.00 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.

KBC Groupe NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):